NANO-X IMAGING LTD
NNOXNASDAQTrading Snapshot
- Day Range
- $0.65 – $0.67
- 52-Week Range
- $0.63 – $4.71
- Volume
- $2.76B
- Avg Volume
- $3.08B
- Shares Outstanding
- 69.6M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $13M
- Last Q Revenue
- $4M
- P/E Ratio
- -0.4
- P/S Ratio
- 2.9x
- EPS (TTM)
- $-1.67
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +11.5%
Why Investors Own NNOX
- ✓High-growth profile — revenue up -4.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 51% gross margin and 19% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
NANO-X IMAGING LTD
NNOX
StockOtter · stockotter.spaceAbout NANO-X IMAGING LTD
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
NANO-X IMAGING LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift NNOX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
NANO-X IMAGING LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.